Reimbursed Care Access in El Salvador

Currently classified as a strictly controlled substance under national drug-scheduling laws, with no authorized medical use outside of approved clinical research. National legislation and implementing regulations in El Salvador list “alucinógenos” among substances whose importation, production, possession or use is prohibited except with express authorization from health authorities for research or manufacture of medicines #.

Currently classified as a strictly controlled substance under national drug-scheduling laws, with no authorized medical use outside of approved clinical research. The national framework prohibits activities with ‘‘alucinógenos’’ and requires authorization from the Consejo Superior de Salud Pública (or equivalent health authorities) for scientific research or manufacture for medical products. There is no public reimbursement pathway for MDMA-assisted therapy in El Salvador outside authorized clinical studies. #.

Esketamine (pharmaceutical product such as Spravato®) is not documented as a registered, routinely reimbursed product in El Salvador’s public-sector medicine lists; by contrast, the public and social security formularies explicitly include generic ketamine for anesthetic uses. Ketamine (the racemate) is included on El Salvador’s essential/anesthesia medicine listings used by public institutions (Instituto Salvadoreño del Seguro Social and PAHO annotated national lists) as an injectable anesthetic, indicating routine public-sector availability for surgical and emergency care but not routine use as a reimbursed, supervised antidepressant formulation. There is no public evidence of Spravato® (esketamine nasal-spray) national registration or inclusion on the Ministry of Health / social security reimbursable medicine lists at the time of this report; therefore, clinical access would be limited to authorized clinical trials or importation under special authorizations, and it would not be routinely reimbursed by public insurance. # #.

Ketamine (racemic ketamine chloride) is an established, registered anesthetic and analgesic within El Salvador’s public health system and appears in national institutional medicine lists for anesthetic use; it is routinely available in public hospitals for surgical, emergency and pain indications. Public-sector inclusion indicates procurement and reimbursement for standard anesthetic/analgesic indications through the national social security and public hospital supply chains. Off-label use (for psychiatric indications such as treatment‑resistant depression) would be clinician-driven and not part of an established, reimbursed, supervised psychedelic-assisted therapy program—such off-label psychiatric use is therefore typically private (out‑of‑pocket) or done within research settings and not paid as a standard reimbursable therapy by public insurers. Regulatory control requires that any non-standard or investigational use receive authorization from health authorities. # #.

Currently classified as a strictly controlled substance under national drug-scheduling laws, with no authorized medical use outside of approved clinical research. The national law’s prohibition on ‘alucinógenos’ means DMT is not available for routine medical practice or reimbursement and would only be accessible under explicit authorization for scientific research. #.

Currently classified as a strictly controlled substance under national drug-scheduling laws, with no authorized medical use outside of approved clinical research. There is no established medical program or reimbursement mechanism for 5‑MeO‑DMT in El Salvador; access would be limited to formally authorized research. #.

Currently classified as a strictly controlled substance under national drug-scheduling laws, with no authorized medical use outside of approved clinical research. Ibogaine is not part of routine medical practice or reimbursed care in El Salvador and would require special authorization for any research use. #.

Currently classified as a strictly controlled substance under national drug-scheduling laws, with no authorized medical use outside of approved clinical research. National law treats plant-derived hallucinogens and preparations as falling within the regulated category of ‘‘plantas o partes de ellas’’ used to manufacture prohibited drugs, so ritual/ceremonial use would still be subject to prohibition unless expressly permitted by health authorities. Any authorized therapeutic or research use would need prior government authorization. #.

Currently classified as a strictly controlled substance under national drug-scheduling laws, with no authorized medical use outside of approved clinical research. The statutory language in the national drug law includes ‘‘alucinógenos’’ and plant parts used as source material in the general prohibition; therefore mescaline and peyote-derived mescaline have no routine medical authorization or reimbursement in El Salvador unless specifically authorized for scientific research. (Note: independent religious or indigenous exemptions would require explicit legal recognition and are not evident in national drug‑control texts consulted.) #.

Currently classified as a strictly controlled substance under national drug-scheduling laws, with no authorized medical use outside of approved clinical research. Emerging synthetic phenethylamine psychedelics (2C-x series) are within the scope of prohibited ‘‘alucinógenos’’ and novel psychoactive substances and would only be accessible via authorized research channels. #.